Welcome to our dedicated page for Ingersoll-Rand news (Ticker: IR), a resource for investors and traders seeking the latest updates and insights on Ingersoll-Rand stock.
Ingersoll Rand Inc. reports developments tied to its mission-critical flow creation, life science and industrial solutions portfolio. Company news commonly covers operating results, order and revenue trends, segment performance, and regular capital-return actions such as cash dividends.
Updates also include bolt-on acquisitions that expand technologies within areas such as metering and dosing, compression, blower and vacuum, and fluid management. Recent acquisition activity added hydropneumatic accumulators, pulsation dampeners, calibration pots and instrumentation to the Precision and Science Technologies segment. Other recurring announcements address sustainability recognition, investor conference participation, governance matters and business outlook commentary.
Ingersoll Rand (NYSE: IR) will release its Q4 2025 earnings after market close on February 12, 2026 and will host a live conference call to discuss results on February 13, 2026 at 8:00 a.m. ET. Participants can join by dialing +1-888-330-3073 (U.S.) or +1-646-960-0683 (international) using access code 8970061.
A real-time audio webcast and related materials will be posted in the Events and Presentations section of the Ingersoll Rand Investor Relations website prior to the call, and a replay will be available after the conference concludes.
Ingersoll Rand (NYSE: IR) acquired Scinomix, a U.S.-based designer and manufacturer of lab automation technologies, on Jan. 5, 2026 to expand its life sciences portfolio. The deal integrates Scinomix into the Precision and Science Technologies Life Sciences platform and aims to deliver end-to-end solutions for sample management, labeling, barcode scanning, handling, and capping across clinical, pharma, biotech, forensic, agricultural, and genetic testing labs.
The company said the purchase was made at an attractive pre-synergy multiple of ~10x 2025 Adjusted EBITDA, and management highlighted scalable automation, improved throughput, accuracy, and traceability as strategic benefits.
Ingersoll Rand (NYSE: IR) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 7:30 a.m. Pacific Time. Senior management attending includes chairman & CEO Vicente Reynal, CFO Vik Kini, and Scott Watson, SVP and GM, Life Science Technologies.
A real-time audio webcast of the fireside chat will be available via the Events and Presentations section of the Ingersoll Rand Investor Relations website, and a replay will be posted after the presentation.
Ingersoll Rand (NYSE: IR) announced that Jerome Guillen will join its Board of Directors, effective January 1, 2026. Guillen brings more than two decades of leadership in automotive and transportation, including senior roles at Tesla where he helped launch the Model S and Semi truck programs and led engineering, supply chain, manufacturing, automation, and sustainable-technology initiatives.
His background also includes leadership roles at Daimler and McKinsey and current advisory positions to technology firms and a board seat at Vale Base Metals. Management says his experience in transformative projects and operational excellence will support Ingersoll Rand’s focus on sustainable organic growth and innovation.
Ingersoll Rand (NYSE: IR) announced on November 3, 2025 the acquisition of Transvac Systems Ltd., a U.K. supplier of ejector solutions and sustainable process technologies, which will join the Industrial Technologies and Services segment.
The deal adds proprietary ejector technology, a specialized engineering team, and packaged hybrid systems combining ejectors with traditional equipment to target sustainability markets such as energy recovery, wastewater treatment, desalination, and clean water reuse. Management described the transaction as a strategic bolt-on executed at an attractive high single-digit upfront purchase multiple, aimed at accelerating engineered-solution growth and supporting decarbonization and water-conservation initiatives.
Ingersoll Rand (NYSE: IR) declared a regular quarterly cash dividend of $0.02 per share, payable on December 4, 2025 to shareholders of record on November 13, 2025.
The announcement covers the dividend amount, the record date and the payment date for common stockholders.
Ingersoll Rand (NYSE: IR) will release third quarter 2025 results after market close on Thursday, October 30, 2025. The company will host a live earnings conference call on Friday, October 31, 2025 at 8:00 a.m. ET to discuss the results.
Investors can join by phone at +1-888-330-3073 (U.S.) or +1-646-960-0683 (international) using access code 8970061. A real-time audio webcast and related materials will be posted in the Events and Presentations section of the Ingersoll Rand Investor Relations website, and a replay will be available after the call.
Ingersoll Rand (NYSE:IR), a global provider of mission-critical flow creation and life science and industrial solutions, has announced its participation in the Morgan Stanley 13th Annual Laguna Conference. Chairman and CEO Vicente Reynal along with CFO Vik Kini will engage in a fireside chat on September 11, 2025, at 7:00 a.m. Pacific Time.
Investors can access a live audio webcast of the presentation through the Events and Presentations section of Ingersoll Rand's Investor Relations website. A replay will be available after the event.
Ingersoll Rand (NYSE:IR) has acquired Dave Barry Plastics, an Ireland-based manufacturer of plastic product solutions for life science and healthcare technology industries. The acquisition was completed at a 9x 2024 Adjusted EBITDA multiple.
Dave Barry Plastics specializes in clean room solutions designed to minimize contamination risks during manufacturing, packaging, and storage processes. The company will be integrated into Ingersoll Rand's Life Sciences platform within the Precision and Science Technologies (P&ST) segment.
This bolt-on acquisition aligns with Ingersoll Rand's growth strategy, focusing on innovation and market expansion in the life sciences sector.
Ingersoll Rand (NYSE:IR) reported strong Q2 2025 results with record orders of $1,940 million (up 8%) and revenues of $1,888 million (up 5%). The company posted a reported net loss of $115 million ($0.29 per share), while adjusted net income reached $325 million ($0.80 per share). Adjusted EBITDA grew 3% to $509 million.
The Industrial Technologies and Services segment saw orders up 7% to $1,561 million, while Precision and Science Technologies reported orders up 13% to $379 million. The company maintains strong liquidity of $3.9 billion and completed strategic acquisitions of Lead Fluid and TMIC. Ingersoll Rand raised its full-year 2025 guidance and returned $508 million to shareholders through share repurchases and dividends.